h1

h2

h3

h4

h5
h6

001     968620
005     20231009145732.0
024 7 _ |2 ISSN
|a 2055-5822
024 7 _ |2 SCOPUS
|a SCOPUS:2-s2.0-85139803351
024 7 _ |2 WOS
|a WOS:000867486000001
024 7 _ |2 doi
|a 10.1002/ehf2.14197
024 7 _ |2 pmid
|a pmid:36229988
037 _ _ |a RWTH-2023-08689
041 _ _ |a English
082 _ _ |a 610
100 1 _ |a Abdin, Amr
|b 0
245 _ _ |a A practical approach to the guideline‐directed pharmacological treatment of heart failure with reduced ejection fraction
|h online
260 _ _ |a Chichester
|b Wiley
|c 2023
336 7 _ |0 0
|2 EndNote
|a Journal Article
336 7 _ |0 PUB:(DE-HGF)16
|2 PUB:(DE-HGF)
|a Journal Article
|b journal
|m journal
|s 1694164354_38752
336 7 _ |2 BibTeX
|a ARTICLE
336 7 _ |2 DRIVER
|a article
336 7 _ |2 DataCite
|a Output Types/Journal article
336 7 _ |2 ORCID
|a JOURNAL_ARTICLE
536 _ _ |0 G:(GEPRIS)322900939
|a DFG project 322900939 - TRR 219: Mechanismen kardiovaskulärer Komplikationen bei chronischer Niereninsuffizienz (322900939)
|c 322900939
|x 0
588 _ _ |a Dataset connected to CrossRef, Journals: publications.rwth-aachen.de
591 _ _ |a Germany
700 1 _ |a Bauersachs, Johann
|b 1
700 1 _ |a Soltani, Samira
|b 2
700 1 _ |a Eden, Matthias
|b 3
700 1 _ |a Frey, Norbert
|b 4
700 1 _ |0 P:(DE-588)1096256169
|a Böhm, Michael
|b 5
773 _ _ |0 PERI:(DE-600)2814355-3
|a 10.1002/ehf2.14197
|n 1
|p 24-31
|t ESC heart failure
|v 10
|x 2055-5822
|y 2023
914 1 _ |y 2023
915 1 _ |0 StatID:(DE-HGF)0031
|2 StatID
|a Peer reviewed article
|x 0
915 _ _ |0 StatID:(DE-HGF)0030
|2 StatID
|a Peer Review
|b DOAJ : Anonymous peer review
|d 2021-04-16T15:13:20Z
915 _ _ |0 StatID:(DE-HGF)0100
|2 StatID
|a JCR
|b ESC HEART FAIL : 2021
|d 2022-11-09
915 _ _ |0 StatID:(DE-HGF)0113
|2 StatID
|a WoS
|b Science Citation Index Expanded
|d 2022-11-09
915 _ _ |0 StatID:(DE-HGF)0113
|2 StatID
|a WoS
|b Science Citation Index Expanded
|d 2023-08-31
915 _ _ |0 StatID:(DE-HGF)0150
|2 StatID
|a DBCoverage
|b Web of Science Core Collection
|d 2022-11-09
915 _ _ |0 StatID:(DE-HGF)0150
|2 StatID
|a DBCoverage
|b Web of Science Core Collection
|d 2023-08-31
915 _ _ |0 StatID:(DE-HGF)0160
|2 StatID
|a DBCoverage
|b Essential Science Indicators
|d 2022-11-09
915 _ _ |0 StatID:(DE-HGF)0160
|2 StatID
|a DBCoverage
|b Essential Science Indicators
|d 2023-08-31
915 _ _ |0 StatID:(DE-HGF)0199
|2 StatID
|a DBCoverage
|b Clarivate Analytics Master Journal List
|d 2022-11-09
915 _ _ |0 StatID:(DE-HGF)0199
|2 StatID
|a DBCoverage
|b Clarivate Analytics Master Journal List
|d 2023-08-31
915 _ _ |0 StatID:(DE-HGF)0200
|2 StatID
|a DBCoverage
|b SCOPUS
|d 2022-11-09
915 _ _ |0 StatID:(DE-HGF)0200
|2 StatID
|a DBCoverage
|b SCOPUS
|d 2023-08-31
915 _ _ |0 StatID:(DE-HGF)0300
|2 StatID
|a DBCoverage
|b Medline
|d 2022-11-09
915 _ _ |0 StatID:(DE-HGF)0300
|2 StatID
|a DBCoverage
|b Medline
|d 2023-08-31
915 _ _ |0 StatID:(DE-HGF)0320
|2 StatID
|a DBCoverage
|b PubMed Central
|d 2023-08-31
915 _ _ |0 StatID:(DE-HGF)0500
|2 StatID
|a DBCoverage
|b DOAJ
|d 2021-04-16T15:13:20Z
915 _ _ |0 StatID:(DE-HGF)0501
|2 StatID
|a DBCoverage
|b DOAJ Seal
|d 2021-04-16T15:13:20Z
915 _ _ |0 StatID:(DE-HGF)0561
|2 StatID
|a Article Processing Charges
|d 2022-11-09
915 _ _ |0 StatID:(DE-HGF)0561
|2 StatID
|a Article Processing Charges
|d 2023-08-31
915 _ _ |0 StatID:(DE-HGF)0700
|2 StatID
|a Fees
|d 2022-11-09
915 _ _ |0 StatID:(DE-HGF)0700
|2 StatID
|a Fees
|d 2023-08-31
915 _ _ |0 StatID:(DE-HGF)1110
|2 StatID
|a DBCoverage
|b Current Contents - Clinical Medicine
|d 2022-11-09
915 _ _ |0 StatID:(DE-HGF)1110
|2 StatID
|a DBCoverage
|b Current Contents - Clinical Medicine
|d 2023-08-31
915 _ _ |0 StatID:(DE-HGF)9900
|2 StatID
|a IF < 5
|d 2022-11-09
980 1 _ |a EXTERN4COORD
980 _ _ |a I:(DE-82)022000_20140101
980 _ _ |a I:(DE-HGF)0
980 _ _ |a UNRESTRICTED
980 _ _ |a journal

LibraryCollectionCLSMajorCLSMinorLanguageAuthor
Marc 21